503b glp-1/gip injections The FDA is proposing the removal of three GLP-1 drugs from the bulks list of active ingredients that outsourcing facilities can use to make compounded medicines, the agency announced on Thursday GLP-1 Therapy Weight Loss Medication

Transitional changes in medication-initiator cohort profiles in persons with chronic kidney disease and type 2 diabetesa hospital-based cohort study in Japan

Selective pharmacology helps

The benefits of SGLT2i treatment are robustly supported in secondary prevention of CVD and HF, with an increasing wealth of evidence demonstrating significant benefits in people with no established CVD or HF [50,51,52,53,54, 56, 59, 85, 97]

Tirzepatide combines GLP-1 and GIP receptor agonism

Stress management protocols including non-sleep deep rest (NSDR), meditation, breathwork and outdoor activities can help regulate stress hormones like adrenaline and cortisol